Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease

Title: Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease
Authors: Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C.
Source: Gene (Amst.) 535 (2014): 365–369. doi:10.1016/j.gene.2013.09.058 ; info:cnr-pdr/source/autori:Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C./titolo:Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease/doi:10.1016j.gene.2013.09.058/rivista:Gene (Amst.)/anno:2014/pagina_da:365/pagina_a:369/intervallo_pagine:365–369/volume:535
Publisher Information: , Shannon ;, Paesi Bassi
Publication Year: 2014
Collection: PUMAlab (ISTI CNR - Consiglio Nazionale delle Ricerche / National Research Council)
Subject Terms: fabry disease; GLA gene
Description: Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of ?-galactosidase A (?-gal A), a lysosomal hydrolase. This inactivation is responsible for the accumulation of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. Fabry is considered a rare disease, with an incidence of 1:40,000; however, there are good reasons to believe that it is often seen but rarely diagnosed. To date, more than 600 mutations have been identified in human GLA gene that are responsible for FD. We describe the case of a 54-year-old male patient, who presented with left ventricular hypertrophy, chronic renal failure and acroparaesthesias, which are considered to be specific features of FD. Clinical and instrumental investigations showed several cardiovascular manifestations. The molecular analysis of GLA gene revealed a novel mutation in the fifth exon, called N249K, and the enzymatic analysis showed no ?-galactosidase A activity. Family screening detected the same mutation in some relatives and also the enzymatic analysis confirmed the diagnosis of FD. In conclusion, these data suggest that the N249K mutation may be associated with cardiac manifestations of FD combined with other classical features of the disease.
Document Type: article in journal/newspaper
Language: English
Relation: info:cnr-pdr/author/idpersonaleesterno:15790/ZIZZO/CARMELA; info:cnr-pdr/author/matricola:1503/ALBEGGIANI/GIUSEPPE; info:cnr-pdr/author/matricola:4559/DURO/GIOVANNI; info:cnr-pdr/author/matricola:14857/COLOMBA/PAOLO; http://www.cnr.it/prodotto/i/278396; https://publications.cnr.it/doc/278396; https://dx.doi.org/10.1016/j.gene.2013.09.058; info:doi:10.1016/j.gene.2013.09.058
DOI: 10.1016/j.gene.2013.09.058
Availability: http://www.cnr.it/prodotto/i/278396; https://publications.cnr.it/doc/278396; https://doi.org/10.1016/j.gene.2013.09.058
Rights: info:eu-repo/semantics/closedAccess
Accession Number: edsbas.E7B52762
Database: BASE